179 citations
,
October 2018 in “American Journal of Clinical Dermatology”
Cancer treatments targeting specific cells and the immunesystem can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.
Some cancer and immunesystem drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.
Hair loss discussion includes treatments Minoxidil, Finasteride, and RU58841. Prolactin's role in immunesystem's antitumor activity raises safety concerns for HMI-115.
COVID and COVID vaccination can trigger hair loss, primarily telogen effluvium, due to stress and immunesystem activation. Proper diagnosis and addressing factors like nutrition and stress are crucial for recovery.
The conclusion of the conversation is that the user "Shakalakaplaka" shares their comprehensive hair loss regimen, which includes various treatments targeting different pathways such as DHT, inflammation, fibrosis, immunesystem, testosterone, gut problems, and scalp health. The effectiveness of the regimen is not confirmed, and some users express skepticism or request before and after pictures for credibility.
The conversation is about whether it is safe to take Xeljanz, a JAK inhibitor, while also taking finasteride for hair loss. The concern is that Xeljanz weakens the immunesystem, which could be risky.
PP405 may damage hair follicles if used long-term, suggesting cycling might be necessary. Combining it with finasteride could help maintain hair growth.